TOPICAL HAPTEN LIQUID 20 % — DIN 02466341
HAPTENS : 20 % · DORMER LABORATORIES INC. · LIQUID · wholesale supply in Canada
Health Canada status: MARKETED
What is TOPICAL HAPTEN LIQUID?
TOPICAL HAPTEN LIQUID 20 % contains HAPTENS : 20 %. It is listed in the Health Canada Drug Product Database under DIN 02466341, held by DORMER LABORATORIES INC., supplied as LIQUID for TOPICAL administration. Health Canada currently lists it as marketed, status dated 13-Sep-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Is there a generic Tests For Allergic Diseases in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
5 holders have a Canadian DIN containing Tests For Allergic Diseases, across 10 DINs, of which 8 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| DORMER LABORATORIES INC. | 4 | 4 | TOPICAL HAPTEN GEL, TOPICAL HAPTEN LIQUID | Sourceable in Canada |
| ALK-ABELLO INC | 2 | 2 | HISTATROL | Sourceable in Canada |
| JUBILANT HOLLISTERSTIER LLC | 2 | 2 | NEGATIVE SKIN TEST CONTROL - GLYCERIN, POSITIVE SKIN TEST CONTROL-HISTAMINE | Sourceable in Canada |
| ALLERGY CANADA LTD | 1 | 0 | ALLERGY CANADA ALLERGEN EXTRACT - DIAGNOSTIC | No marketed DIN |
| MEKOS LABORATORIES APS | 1 | 0 | TRUE TEST | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 20 % |
|---|---|
| Dosage form | LIQUID |
| Route | TOPICAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Tests For Allergic Diseases |
|---|---|
| ATC code | V04CL |
| AHFS class | 92:05.00* ; See footnote |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02466341 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2466341 |
| Brand name | TOPICAL HAPTEN LIQUID |
| Generic / active ingredient | HAPTENS : 20 % |
| Market authorization holder | DORMER LABORATORIES INC. |
| Health Canada schedule | Schedule D |
| ATC code | V04CL |
| ATC anatomical main group | V — Various |
| ATC therapeutic subgroup | V04CL |
| Current status | MARKETED |
| Status date | 13-Sep-2017 |
| Original market date | 2017-09-13 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
8 of 10 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| HISTATROL | 2.75 MG | SOLUTION | ALK-ABELLO INC | MARKETED | 00609692 |
| HISTATROL | 0.275 MG | SOLUTION | ALK-ABELLO INC | MARKETED | 00609706 |
| NEGATIVE SKIN TEST CONTROL - GLYCERIN | 50 % | LIQUID | JUBILANT HOLLISTERSTIER LLC | MARKETED | 02426773 |
| POSITIVE SKIN TEST CONTROL-HISTAMINE | 6 MG | SOLUTION | JUBILANT HOLLISTERSTIER LLC | MARKETED | 02439514 |
| TOPICAL HAPTEN GEL | 50 % | GEL | DORMER LABORATORIES INC. | MARKETED | 02466325 |
| TOPICAL HAPTEN GEL | 100 % | GEL | DORMER LABORATORIES INC. | MARKETED | 02466333 |
| TOPICAL HAPTEN LIQUID | 100 % | LIQUID | DORMER LABORATORIES INC. | MARKETED | 02466368 |
| ALLERGY CANADA ALLERGEN EXTRACT - DIAGNOSTIC | 0 UNIT | SOLUTION | ALLERGY CANADA LTD | DORMANT | 02242717 |
| TRUE TEST | 0.0065 MG | PATCH | MEKOS LABORATORIES APS | CANCELLED POST MARKET | 02271885 |
2 · Same class — other molecules in ATC V04CL
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Tests For Allergic Diseases | ALLERGY CANADA ALLERGEN EXTRACT - DIAGNOSTIC · HISTATROL · NEGATIVE SKIN TEST CONTROL - GLYCERIN · POSITIVE SKIN TEST CONTROL-HISTAMINE · +3 more | 10 | 8 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC V04C
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| V04CX | Indocyanine Green · Other Diagnostic Agents | 59 | 16 |
| V04CC | Sincalide | 3 | 2 |
| V04CF | Tuberculin | 5 | 1 |
| V04CG | Histamine · Methylthionine · Pentagastrin | 5 | 1 |
| V04CD | Tests For Pituitary Function | 1 | 1 |
| V04C | Other Diagnostic Agents | 1 | 0 |
| V04CH | Aminohippuric Acid · Indigo Carmine | 2 | 0 |
| V04CJ | Protirelin | 3 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.